Pirbright secures significant BBSRC investment to advance world-class research
The Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), has announced a new portfolio of strategically important funding that will significantly enhance the UK’s capability to deliver world-leading research with socio-economic impact.
This leading-edge research will be supported by £376 million funding from BBSRC over the next five years, of which The Pirbright Institute will receive £90 million.